GrippePaysBasV1, Main, Exploration, bibRecord, 000139

Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.

Identifieur interne : 000139 ( Main/Exploration ); précédent : 000138; suivant : 000140

Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.

Auteurs : Mariëtte Hooiveld [Pays-Bas] ; Tine Van De Groep ; Theo J M. Verheij ; Marianne A B. Van Der Sande ; Robert A. Verheij ; Margot A J B. Tacken ; Gerrit A. Van Essen

Source :

BMC pharmacology & toxicology [ 2050-6511 ] ; 2013.

RBID : pubmed:24143932

Descripteurs français

KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Antiviraux (administration et posologie), Antiviraux (usage thérapeutique), Dossiers médicaux électroniques (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Femelle (MeSH), Grippe humaine (complications), Grippe humaine (traitement médicamenteux), Grippe humaine (épidémiologie), Guides de bonnes pratiques cliniques comme sujet (normes), Humains (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Médecins généralistes (normes), Médecins généralistes (statistiques et données numériques), Nourrisson (MeSH), Ordonnances médicamenteuses (statistiques et données numériques), Oséltamivir (administration et posologie), Oséltamivir (usage thérapeutique), Pandémies (statistiques et données numériques), Pays-Bas (épidémiologie), Revue des pratiques de prescription des médicaments (MeSH).
MESH :
- administration et posologie : Antiviraux, Oséltamivir.
- normes : Guides de bonnes pratiques cliniques comme sujet, Médecins généralistes.
- statistiques et données numériques : Médecins généralistes, Ordonnances médicamenteuses, Pandémies.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux, Grippe humaine, Oséltamivir.
- épidémiologie : Grippe humaine, Pays-Bas.
- Adolescent, Adulte, Adulte d'âge moyen, Dossiers médicaux électroniques, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Jeune adulte, Mâle, Nourrisson, Revue des pratiques de prescription des médicaments.
Wicri :
- geographic : Pays-Bas.

English descriptors

KwdEn :
- Adolescent (MeSH), Adult (MeSH), Antiviral Agents (administration & dosage), Antiviral Agents (therapeutic use), Child (MeSH), Child, Preschool (MeSH), Drug Prescriptions (statistics & numerical data), Drug Utilization Review (MeSH), Electronic Health Records (MeSH), Female (MeSH), General Practitioners (standards), General Practitioners (statistics & numerical data), Humans (MeSH), Infant (MeSH), Influenza, Human (complications), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Male (MeSH), Middle Aged (MeSH), Netherlands (epidemiology), Oseltamivir (administration & dosage), Oseltamivir (therapeutic use), Pandemics (statistics & numerical data), Practice Guidelines as Topic (standards), Young Adult (MeSH).
MESH :
- chemical , administration & dosage : Antiviral Agents, Oseltamivir.
- chemical , therapeutic use : Antiviral Agents, Oseltamivir.
- geographic , epidemiology : Netherlands.
- complications : Influenza, Human.
- drug therapy : Influenza, Human.
- epidemiology : Influenza, Human.
- standards : General Practitioners, Practice Guidelines as Topic.
- statistics & numerical data : Drug Prescriptions, General Practitioners, Pandemics.
- Adolescent, Adult, Child, Child, Preschool, Drug Utilization Review, Electronic Health Records, Female, Humans, Infant, Male, Middle Aged, Young Adult.

Abstract

BACKGROUND

After the clinical impact of the A(H1N1) pdm09 virus was considered to be mild, treatment with antiviral drugs was recommended only to patients who were at risk for severe disease or who had a complicated course of influenza. We investigated to what extent antiviral prescriptions in primary care practices were in accordance with the recommendations, what proportion of patients diagnosed with influenza had been prescribed antiviral drugs, and to what extent prescriptions related to the stated indications for antiviral treatment.

METHODS

We used data from routine electronic medical records of practices participating in the Netherlands Information Network of General Practice LINH in the period August-December 2009. We considered patient and practice characteristics, clinical diagnoses and drug prescriptions of all patients who contacted their general practitioner in the given period and who had been prescribed antiviral medication (n=351) or were diagnosed with influenza (n=3293).

RESULTS

Of all antiviral prescriptions, 69% were in accordance with the recommendations. Only 5% of patients diagnosed with influenza were prescribed antiviral drugs. This percentage increased to 12% among influenza patients belonging to the designated high risk groups. On the other hand, 2.5% of influenza patients not at high risk of complications received antiviral treatment. In addition to the established high risk factors, the total number of drug prescriptions for a patient in this year was a determinant of antiviral prescriptions. Information on time since onset of symptoms and the clinical presentation of patients was not available.

CONCLUSIONS

General practitioners in the Netherlands have been restrictive in prescribing antiviral drugs during the influenza pandemic, even when patients met the criteria for antiviral treatment.

DOI: 10.1186/2050-6511-14-55
PubMed: 24143932
PubMed Central: PMC3854647

Affiliations:

Pays-Bas

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000132
to stream Main, to step Curation: 000132

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.</title>
<author><name sortKey="Hooiveld, Mariette" sort="Hooiveld, Mariette" uniqKey="Hooiveld M" first="Mariëtte" last="Hooiveld">Mariëtte Hooiveld</name>
<affiliation wicri:level="1"><nlm:affiliation>NIVEL, Netherlands Institute for Health Services Research, Utrecht, PO Box 1568, 3500 BN Utrecht, the Netherlands. m.hooiveld@nivel.nl.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>NIVEL, Netherlands Institute for Health Services Research, Utrecht, PO Box 1568, 3500 BN Utrecht</wicri:regionArea>
<wicri:noRegion>3500 BN Utrecht</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van De Groep, Tine" sort="Van De Groep, Tine" uniqKey="Van De Groep T" first="Tine" last="Van De Groep">Tine Van De Groep</name>
</author>
<author><name sortKey="Verheij, Theo J M" sort="Verheij, Theo J M" uniqKey="Verheij T" first="Theo J M" last="Verheij">Theo J M. Verheij</name>
</author>
<author><name sortKey="Van Der Sande, Marianne A B" sort="Van Der Sande, Marianne A B" uniqKey="Van Der Sande M" first="Marianne A B" last="Van Der Sande">Marianne A B. Van Der Sande</name>
</author>
<author><name sortKey="Verheij, Robert A" sort="Verheij, Robert A" uniqKey="Verheij R" first="Robert A" last="Verheij">Robert A. Verheij</name>
</author>
<author><name sortKey="Tacken, Margot A J B" sort="Tacken, Margot A J B" uniqKey="Tacken M" first="Margot A J B" last="Tacken">Margot A J B. Tacken</name>
</author>
<author><name sortKey="Van Essen, Gerrit A" sort="Van Essen, Gerrit A" uniqKey="Van Essen G" first="Gerrit A" last="Van Essen">Gerrit A. Van Essen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:24143932</idno>
<idno type="pmid">24143932</idno>
<idno type="doi">10.1186/2050-6511-14-55</idno>
<idno type="pmc">PMC3854647</idno>
<idno type="wicri:Area/Main/Corpus">000132</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000132</idno>
<idno type="wicri:Area/Main/Curation">000132</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000132</idno>
<idno type="wicri:Area/Main/Exploration">000132</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.</title>
<author><name sortKey="Hooiveld, Mariette" sort="Hooiveld, Mariette" uniqKey="Hooiveld M" first="Mariëtte" last="Hooiveld">Mariëtte Hooiveld</name>
<affiliation wicri:level="1"><nlm:affiliation>NIVEL, Netherlands Institute for Health Services Research, Utrecht, PO Box 1568, 3500 BN Utrecht, the Netherlands. m.hooiveld@nivel.nl.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>NIVEL, Netherlands Institute for Health Services Research, Utrecht, PO Box 1568, 3500 BN Utrecht</wicri:regionArea>
<wicri:noRegion>3500 BN Utrecht</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van De Groep, Tine" sort="Van De Groep, Tine" uniqKey="Van De Groep T" first="Tine" last="Van De Groep">Tine Van De Groep</name>
</author>
<author><name sortKey="Verheij, Theo J M" sort="Verheij, Theo J M" uniqKey="Verheij T" first="Theo J M" last="Verheij">Theo J M. Verheij</name>
</author>
<author><name sortKey="Van Der Sande, Marianne A B" sort="Van Der Sande, Marianne A B" uniqKey="Van Der Sande M" first="Marianne A B" last="Van Der Sande">Marianne A B. Van Der Sande</name>
</author>
<author><name sortKey="Verheij, Robert A" sort="Verheij, Robert A" uniqKey="Verheij R" first="Robert A" last="Verheij">Robert A. Verheij</name>
</author>
<author><name sortKey="Tacken, Margot A J B" sort="Tacken, Margot A J B" uniqKey="Tacken M" first="Margot A J B" last="Tacken">Margot A J B. Tacken</name>
</author>
<author><name sortKey="Van Essen, Gerrit A" sort="Van Essen, Gerrit A" uniqKey="Van Essen G" first="Gerrit A" last="Van Essen">Gerrit A. Van Essen</name>
</author>
</analytic>
<series><title level="j">BMC pharmacology & toxicology</title>
<idno type="eISSN">2050-6511</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Drug Prescriptions (statistics & numerical data)</term>
<term>Drug Utilization Review (MeSH)</term>
<term>Electronic Health Records (MeSH)</term>
<term>Female (MeSH)</term>
<term>General Practitioners (standards)</term>
<term>General Practitioners (statistics & numerical data)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Netherlands (epidemiology)</term>
<term>Oseltamivir (administration & dosage)</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Pandemics (statistics & numerical data)</term>
<term>Practice Guidelines as Topic (standards)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Dossiers médicaux électroniques (MeSH)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (complications)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Guides de bonnes pratiques cliniques comme sujet (normes)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Médecins généralistes (normes)</term>
<term>Médecins généralistes (statistiques et données numériques)</term>
<term>Nourrisson (MeSH)</term>
<term>Ordonnances médicamenteuses (statistiques et données numériques)</term>
<term>Oséltamivir (administration et posologie)</term>
<term>Oséltamivir (usage thérapeutique)</term>
<term>Pandémies (statistiques et données numériques)</term>
<term>Pays-Bas (épidémiologie)</term>
<term>Revue des pratiques de prescription des médicaments (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term>
<term>Oseltamivir</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
<term>Oseltamivir</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Netherlands</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term>
<term>Oséltamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Médecins généralistes</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>General Practitioners</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Drug Prescriptions</term>
<term>General Practitioners</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Médecins généralistes</term>
<term>Ordonnances médicamenteuses</term>
<term>Pandémies</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Grippe humaine</term>
<term>Oséltamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Pays-Bas</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Drug Utilization Review</term>
<term>Electronic Health Records</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Dossiers médicaux électroniques</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Revue des pratiques de prescription des médicaments</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Pays-Bas</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>After the clinical impact of the A(H1N1) pdm09 virus was considered to be mild, treatment with antiviral drugs was recommended only to patients who were at risk for severe disease or who had a complicated course of influenza. We investigated to what extent antiviral prescriptions in primary care practices were in accordance with the recommendations, what proportion of patients diagnosed with influenza had been prescribed antiviral drugs, and to what extent prescriptions related to the stated indications for antiviral treatment.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>We used data from routine electronic medical records of practices participating in the Netherlands Information Network of General Practice LINH in the period August-December 2009. We considered patient and practice characteristics, clinical diagnoses and drug prescriptions of all patients who contacted their general practitioner in the given period and who had been prescribed antiviral medication (n=351) or were diagnosed with influenza (n=3293).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Of all antiviral prescriptions, 69% were in accordance with the recommendations. Only 5% of patients diagnosed with influenza were prescribed antiviral drugs. This percentage increased to 12% among influenza patients belonging to the designated high risk groups. On the other hand, 2.5% of influenza patients not at high risk of complications received antiviral treatment. In addition to the established high risk factors, the total number of drug prescriptions for a patient in this year was a determinant of antiviral prescriptions. Information on time since onset of symptoms and the clinical presentation of patients was not available.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>General practitioners in the Netherlands have been restrictive in prescribing antiviral drugs during the influenza pandemic, even when patients met the criteria for antiviral treatment.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24143932</PMID>
<DateCompleted><Year>2014</Year>
<Month>06</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-6511</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>14</Volume>
<PubDate><Year>2013</Year>
<Month>Oct</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>BMC pharmacology & toxicology</Title>
<ISOAbbreviation>BMC Pharmacol Toxicol</ISOAbbreviation>
</Journal>
<ArticleTitle>Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.</ArticleTitle>
<Pagination><MedlinePgn>55</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/2050-6511-14-55</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">After the clinical impact of the A(H1N1) pdm09 virus was considered to be mild, treatment with antiviral drugs was recommended only to patients who were at risk for severe disease or who had a complicated course of influenza. We investigated to what extent antiviral prescriptions in primary care practices were in accordance with the recommendations, what proportion of patients diagnosed with influenza had been prescribed antiviral drugs, and to what extent prescriptions related to the stated indications for antiviral treatment.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We used data from routine electronic medical records of practices participating in the Netherlands Information Network of General Practice LINH in the period August-December 2009. We considered patient and practice characteristics, clinical diagnoses and drug prescriptions of all patients who contacted their general practitioner in the given period and who had been prescribed antiviral medication (n=351) or were diagnosed with influenza (n=3293).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of all antiviral prescriptions, 69% were in accordance with the recommendations. Only 5% of patients diagnosed with influenza were prescribed antiviral drugs. This percentage increased to 12% among influenza patients belonging to the designated high risk groups. On the other hand, 2.5% of influenza patients not at high risk of complications received antiviral treatment. In addition to the established high risk factors, the total number of drug prescriptions for a patient in this year was a determinant of antiviral prescriptions. Information on time since onset of symptoms and the clinical presentation of patients was not available.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">General practitioners in the Netherlands have been restrictive in prescribing antiviral drugs during the influenza pandemic, even when patients met the criteria for antiviral treatment.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hooiveld</LastName>
<ForeName>Mariëtte</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>NIVEL, Netherlands Institute for Health Services Research, Utrecht, PO Box 1568, 3500 BN Utrecht, the Netherlands. m.hooiveld@nivel.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>van de Groep</LastName>
<ForeName>Tine</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Verheij</LastName>
<ForeName>Theo J M</ForeName>
<Initials>TJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>van der Sande</LastName>
<ForeName>Marianne A B</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Verheij</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tacken</LastName>
<ForeName>Margot A J B</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>van Essen</LastName>
<ForeName>Gerrit A</ForeName>
<Initials>GA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>10</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>BMC Pharmacol Toxicol</MedlineTA>
<NlmUniqueID>101590449</NlmUniqueID>
<ISSNLinking>2050-6511</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017723" MajorTopicYN="Y">Drug Utilization Review</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058005" MajorTopicYN="N">General Practitioners</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>06</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>10</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>10</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>10</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>6</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24143932</ArticleId>
<ArticleId IdType="pii">2050-6511-14-55</ArticleId>
<ArticleId IdType="doi">10.1186/2050-6511-14-55</ArticleId>
<ArticleId IdType="pmc">PMC3854647</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Prev Med. 2002 Oct;35(4):401-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12453719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2004 Aug 13;22(23-24):2985-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15297046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 1998 Sep 26;317(7162):858-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9748183</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2010 Jan 14;15(2). pii: 19461</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20085691</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Infect Dis. 2012 Apr;44(4):306-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22026440</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2011 Jan 4;154(1):74-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21200049</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Public Health. 2012 Feb;22(1):150-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21183472</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2012 Mar;18(3):534-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22377063</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Technol Assess. 2010 Jul;14(34):109-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20630123</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Pays-Bas</li>
</country>
</list>
<tree><noCountry><name sortKey="Tacken, Margot A J B" sort="Tacken, Margot A J B" uniqKey="Tacken M" first="Margot A J B" last="Tacken">Margot A J B. Tacken</name>
<name sortKey="Van De Groep, Tine" sort="Van De Groep, Tine" uniqKey="Van De Groep T" first="Tine" last="Van De Groep">Tine Van De Groep</name>
<name sortKey="Van Der Sande, Marianne A B" sort="Van Der Sande, Marianne A B" uniqKey="Van Der Sande M" first="Marianne A B" last="Van Der Sande">Marianne A B. Van Der Sande</name>
<name sortKey="Van Essen, Gerrit A" sort="Van Essen, Gerrit A" uniqKey="Van Essen G" first="Gerrit A" last="Van Essen">Gerrit A. Van Essen</name>
<name sortKey="Verheij, Robert A" sort="Verheij, Robert A" uniqKey="Verheij R" first="Robert A" last="Verheij">Robert A. Verheij</name>
<name sortKey="Verheij, Theo J M" sort="Verheij, Theo J M" uniqKey="Verheij T" first="Theo J M" last="Verheij">Theo J M. Verheij</name>
</noCountry>
<country name="Pays-Bas"><noRegion><name sortKey="Hooiveld, Mariette" sort="Hooiveld, Mariette" uniqKey="Hooiveld M" first="Mariëtte" last="Hooiveld">Mariëtte Hooiveld</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000139 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000139 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippePaysBasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24143932
   |texte=   Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24143932" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippePaysBasV1

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 10:18:30 2020. Site generation: Sat Mar 27 13:53:34 2021

	Serveur d'exploration sur la grippe aux Pays-Bas
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe aux Pays-Bas

Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.

Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki